Prosecution Insights
Last updated: April 19, 2026

Abraxis Bioscience LLC

2 pending office actions

Portfolio Summary

2
Total Pending OAs
2
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17438825 SUBCUTANEOUS ADMINISTRATION OF NANOPARTICLES COMPRISING AN MTOR INHIBITOR AND ALBUMIN FOR TREATMENT OF DISEASES VISHNYAKOVA, ELENA VLADIMIROVNA 1691 Final Rejection Sep 13, 2021
16953167 METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION GREENE, IVAN A 1619 Final Rejection Nov 19, 2020

Managing Abraxis Bioscience LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month